• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

18/05/2026 11:36

FDC gets USFDA approval for Cefixime Oral Suspension

FDC has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cefixime for Oral Suspension USP.

The approved product will be available in strengths of 100 mg/5 mL and 200 mg/5 mL, the company said in an exchange filing.